Skip to main content
SpringerLink
Log in

Serum uric acid is not an independent risk factor for coronary heart disease

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Many large epidemiologic studies have confirmed a positive association between raised serum uric acid and risk of coronary heart disease or cardiovascular disease, both in the general population and among hypertensive patients. There is much controversy concerning the role of uric acid as an independent risk factor in the development of coronary heart disease because serum uric acid is related to many of the established etiologic risk factors for cardiovascular disease that could confound the observed association. This review finds little support for an independent causal role for serum uric acid in the development of coronary heart disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Gertler MM, Garn SM, Levine SA: Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 1951, 34:1421–1431.

    PubMed  CAS  Google Scholar 

  2. Klein R, Klein B, Cornoni JC, et al.: Serum uric acid: its relationship to coronary heart disease risk factors and cardiovascular disease, Evans County, Georgia. Arch Intern Med 1973, 132:401–410.

    Article  PubMed  CAS  Google Scholar 

  3. Beard JT: Serum uric acid and coronary heart disease. Am Heart J 1983, 106:397–400.

    Article  PubMed  Google Scholar 

  4. Brand FN, McGee DL, Kannel WB, et al.: Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985, 121:11–18.

    PubMed  CAS  Google Scholar 

  5. Dobson A: Is raised uric acid a cause of cardiovascular disease or death? Lancet 1999, 354:1578. This editorial considers the issue of whether uric acid plays a causal role in the development of cardiovascular disease according to the main criteria for causation as described by Austin Bradford Hill: strength of association, dose-response relation, consistency, specificity, temporal relation, and biologic plausibility.

    Article  PubMed  CAS  Google Scholar 

  6. Wannamethee SG: Is serum uric acid a risk factor for coronary heart disease. J Hum Hypertens 1999, 13:153–156.

    Article  PubMed  CAS  Google Scholar 

  7. Johnson RJ, Kivlighn SD, Kim Y-G, et al.: Reappraisal of the pathogenesis and consequences of hyperuricaemia in hypertension, cardiovascular disease, and renal disease. Am J Kidney Dis 1999, 33:225–234. This editorial review addresses the association of hyperuricemia with cardiovascular disease and discusses the pathogenic role for uric acid in the development of renal disease and hypertension and what should be done about it.

    PubMed  CAS  Google Scholar 

  8. Johnson RJ, Tuttle KR: Much ado about nothing, or much to do about something? The continuing controversy over the role of uric acid in cardiovascular disease. Hypertension 2000, 35:e10.

    PubMed  CAS  Google Scholar 

  9. Rich M: Uric acid: is it a risk factor for cardiovascular disease. Am J Cardiol 2000, 85:1018–1021.

    Article  PubMed  CAS  Google Scholar 

  10. Waring WS, Webb DJ, Maxwell SRJ: Uric acid as a risk factor for cardiovascular disease. Q J Med 2000, 93:707–713. This reviews the possible mechanisms by which hyperuricemia relates to other risk factors, vascular dysfunction, and cardiovascular disease.

    CAS  Google Scholar 

  11. Wannamethee SG, Shaper AG, Whincup PH: Serum urate and the risk of major coronary heart disease events. Heart 1997, 78:147–153.

    PubMed  CAS  Google Scholar 

  12. CulletonBF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7–13. This update paper from the Framingham Heart Study examines the relationship between serum uric acid and CHD events and cardiovascular disease mortality in men and women adjusting for a wide range of risk factors. There was no evidence that serum uric acid is an independent risk factor.

    PubMed  CAS  Google Scholar 

  13. Liese AD, Hense HW, Lowel H, et al.: Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organisation Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology 1999, 10:391–397.

    Article  PubMed  CAS  Google Scholar 

  14. Fang J, Alderman MH: Serum uric acid and cardiovascular mortality. The NHANES I Epidemiologic Follow-up Study, 1971–1992. JAMA 2000, 283:2404–2410.

    Article  PubMed  CAS  Google Scholar 

  15. The Coronary Drug Project Research Group: Serum uric acid: its association with other risk factors and with mortality in coronary heart disease. J Chron Dis 1976, 29:557–569.

    Article  Google Scholar 

  16. Persky VW, Dyer AR, Idris Soven E, et al.: Uric acid: a risk factor for coronary heart disease? Circulation 1979, 59:969–977.

    PubMed  CAS  Google Scholar 

  17. Reunanen A, Takkunen, Knekt P, Aromaa A: Hyperuricaemia as a risk factor for cardiovascular mortality. Acta Med Scand (Suppl) 1982, 668:49–59.

    CAS  Google Scholar 

  18. Yano K, Reed DM, McGee DL: Ten year incidence of coronary heart disease in the Honolulu Heart Program: relationship to biological and lifestyle characteristics. Am J Epidemiol 1984, 119:653–666.

    PubMed  CAS  Google Scholar 

  19. Iribarren C, Sharp DS, Curb JD, Yano K: High uric acid: a metabolic marker of coronary heart disease among alcohol abstainers. J Clin Epidemiol 1996, 49:673–678.

    Article  PubMed  CAS  Google Scholar 

  20. Selby JV, Friedman GD, Quesenberry CP: Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol levels, and other serum chemistries. Am J Epidemiol 1990, 131:1017–1027.

    PubMed  CAS  Google Scholar 

  21. Rathmann W, Funkhouser E, Dyer AR, Roseman JM: Relations of hyperuricaemia with the various components of the insulin resistance syndrome in young black and white adults: The CARDIA Study. Ann Epidemiol 1998, 8:250–261.

    Article  PubMed  CAS  Google Scholar 

  22. Freedman DS, Williamson DF, Gunter EW, Byers T: Relation of serum uric acid to mortality and ischaemic heart disease: the NHANES I epidemiologic follow-up study. Am J Epidemiol 1995, 141:637–644.

    PubMed  CAS  Google Scholar 

  23. Levine W, Dyer A, Shekelle RB, et al.: Serum uric acid and 11.5 year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol 1989, 42:257–267.

    Article  PubMed  CAS  Google Scholar 

  24. Facchini F, Chen YDI, Hollenbeck CB, et al.: Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance and plasma uric concentration. JAMA 1991, 266:3008–3009.

    Article  PubMed  CAS  Google Scholar 

  25. Cappucio FP, Strazzulo P, Farinaro E, et al.: Uric acid metabolism and tubular sodium handling: results from a population-based study. JAMA 1993, 270:354–359.

    Article  Google Scholar 

  26. Lee J, Sparrow D, Vokonas PS, et al.: Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance sysndrome. Am J Epidemiol 1995, 142:288–294.

    PubMed  CAS  Google Scholar 

  27. Staessen J: The Determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly Trial. Am J Med 1991, 90(suppl 3A):50S-53S.

    PubMed  CAS  Google Scholar 

  28. Frost PH, Davis BR, Burlando AJ, et al.: Coronary heart disease risk factors in men and women aged 60 years and older. Findings from the Systolic Hypertension in the Elderly Program. Circulation 1996, 94:26–34.

    PubMed  CAS  Google Scholar 

  29. Alderman MH, Cohen H, Madhavan S, Kivlighn S: Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999, 34:144–150. This study examines the relationship between serum uric acid, myocardial infarction, and CHD deaths in over 7000 hypertensive patients. The relationship was not significant after exclusion of subjects with prevalent CHD.

    PubMed  CAS  Google Scholar 

  30. Verdecchia P, Schillaci G, Reboldi G, et al.: Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the Piuma Study. Hypertension 2000, 36:1072.

    PubMed  CAS  Google Scholar 

  31. Mustard JF, Murphy EA, Ogrzylo MA, et al.: Blood coagulation and platelet economy in subjects with primary gout. Can Med Assoc J 1963, 89:1207–1211.

    PubMed  CAS  Google Scholar 

  32. Newland H: Hyperuricaemia in coronary cerebral and peripherial arterial disease:an explanation. Med Hypotheses 1975, 1:152–155.

    Article  PubMed  CAS  Google Scholar 

  33. Ward HJ: Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998, 352:670–671.

    Article  PubMed  CAS  Google Scholar 

  34. Becker BF: Towards the physiological function of uric acid. Free Rad Biol Med 1993, 14:615–631.

    Article  PubMed  CAS  Google Scholar 

  35. Levya F, Anker S, Swan JW, et al.: Serum uric acid as an impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997, 18:858–865.

    Google Scholar 

  36. Bengtsson C, Lapidus, Stendhal C, et al.: Hyperuricaemia and risk of cardiovascular disease and overall death: a 12 year follow-up study of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand 1988, 224:549–555.

    Article  PubMed  CAS  Google Scholar 

  37. Iribarren C, Folsom AR, Eckfeldt JH, et al.: Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Ann Epidemiol 1996, 6:331–340.

    Article  PubMed  CAS  Google Scholar 

  38. Lieber CS, Davidson CS: Some metabolic effects of ethanol accumulation. Am J Med 1962, 33:319–327.

    Article  PubMed  CAS  Google Scholar 

  39. Perry IJ, Wannamethee SG, Walker M, et al.: Prospective study of risk factors for development of non-insulin dependent diabetes in middle-aged British men. BMJ 1995, 310:560–564.

    PubMed  CAS  Google Scholar 

  40. Gotfredsen A, McNair P, Christiansen C, et al.: Renal hypouricaemia in insulin treated diabetes mellitus. Clin Chim Acta 1982, 120:355–361.

    Article  PubMed  CAS  Google Scholar 

  41. Wannamethee SG, Shaper AG, Durrington PN, Perry IJ: Hypertension, serum insulin, obesity and the metabolic syndrome. J Hum Hypertens 1998, 12:735–741.

    Article  PubMed  CAS  Google Scholar 

  42. Messerli FH, Frohlich ED, Dreslinski GR, et al.: Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 1980, 93:817–821.

    PubMed  CAS  Google Scholar 

  43. Frohlic ED: Uric acid: a risk factor for coronary heart disease. JAMA 1993, 270:378–379.

    Article  Google Scholar 

  44. Kinsey D, Walther R, Sise HS, et al.: Incidence of hyperuricaemia in 400 hypertension patients. Circulation 1961, 24:972–973.

    Google Scholar 

  45. Zalokar J, Lellouch J, Claude JR, et al.: Epidemiology of serum uric acid and gout in Frenchmen. J Chron Dis 1974, 27:59–75.

    Article  PubMed  CAS  Google Scholar 

  46. Bengtsson C: Elevated serum uric acid during treatment with antihypertensive drugs. Acta Med Scand (Suppl) 1979, 628:69–71.

    CAS  Google Scholar 

  47. DeFronzo RA: The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia 1981, 21:165–171.

    Article  PubMed  CAS  Google Scholar 

  48. Modan M, Halkin H: Hyperinsulinaemia or increased sympathetic drive as links for obesity and hypertension. Diabetes Care 1991, 14:470–487.

    Article  PubMed  CAS  Google Scholar 

  49. Krentz AJ: Insulin resistance. BMJ 1996, 313:1385–1389.

    PubMed  CAS  Google Scholar 

  50. Modan M, Halkin H, Karasik A, Lusky A: Elevated serum uric acid-a facet of hyperinsulinaemia. Diabetologia 1987, 30:713–718.

    Article  PubMed  CAS  Google Scholar 

  51. Salomma VV, Tuomilehto J, Jauhainen M, et al.: Hypertriglyceridaemia in different degrees of glucose intolerance in a Finnish population-based study. Diabetes Care 1992, 15:657–665.

    Article  Google Scholar 

  52. Fox IH, John D, DeBruyne S, et al.: Hyperuricaemia and hypertriglyceridaemia: metabolic basis for the association. Metabolism 1985, 34:741–746.

    Article  PubMed  CAS  Google Scholar 

  53. Hoeschen RJ: Oxidative stress and cardiovascular disease. Can J Cardiol 1997, 13:1021–1025.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Primary Care and Population Sciences, Royal Free and University College Medical School, Rowland Hill Street, NW3 2PF, London, UK

    S. Goya Wannamethee PhD

Authors
  1. S. Goya Wannamethee PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wannamethee, S.G. Serum uric acid is not an independent risk factor for coronary heart disease. Current Science Inc 3, 190–196 (2001). https://doi.org/10.1007/s11906-001-0037-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-001-0037-3

Keywords

Search

Navigation